{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:08:01Z","timestamp":1791479281171,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11596-023-2725-6","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:02:14Z","timestamp":1684476134000},"page":"505-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tetrandrine Represses Inflammation and Attenuates Osteoarthritis by Selective Inhibition of COX-2"],"prefix":"10.1007","volume":"43","author":[{"given":"Ping","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-wei","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-ze","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"issue":"6","key":"2725_CR1","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jama.2020.22171","volume":"325","author":"JN Katz","year":"2021","unstructured":"Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA, 2021,325(6):568\u2013578","journal-title":"JAMA"},{"issue":"7","key":"2725_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41584-019-0237-3","volume":"15","author":"CA Emery","year":"2019","unstructured":"Emery CA, Whittaker JL, Mahmoudian A, et al. Establishing outcome measures in early knee osteoarthritis. Nat Rev Rheumatol, 2019,15(7):438\u2013448","journal-title":"Nat Rev Rheumatol"},{"issue":"10182","key":"2725_CR3","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet, 2019,393(10182):1745\u20131759","journal-title":"Lancet"},{"issue":"02","key":"2725_CR4","first-page":"134","volume":"18","author":"B Wang","year":"2018","unstructured":"Wang B, Xing D, Dong S, et al. Prevalence and disease burden of knee osteoarthritis in China: a systematic review. Zhongguo Xunzheng Yixue Zazhi (Chinese), 2018,18(02):134\u2013142","journal-title":"Zhongguo Xunzheng Yixue Zazhi (Chinese)"},{"issue":"9","key":"2725_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","volume":"17","author":"AM Schjerning","year":"2020","unstructured":"Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol, 2020,17(9):574\u2013584","journal-title":"Nat Rev Cardiol"},{"key":"2725_CR6","doi-asserted-by":"publisher","first-page":"114147","DOI":"10.1016\/j.bcp.2020.114147","volume":"180","author":"S Bindu","year":"2020","unstructured":"Bindu S, Mazumder S, Bandyopadhyay U. Nonsteroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol, 2020,180:114147","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2725_CR7","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.semarthrit.2015.11.009","volume":"45","author":"J-P Pelletier","year":"2016","unstructured":"Pelletier J-P, Martel-Pelletier J, Rannou F, et al. Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum, 2016,45(4):S22\u2013S27","journal-title":"Semin Arthritis Rheum"},{"key":"2725_CR8","doi-asserted-by":"publisher","first-page":"107659","DOI":"10.1016\/j.pharmthera.2020.107659","volume":"217","author":"W Xu","year":"2021","unstructured":"Xu W, Chen S, Wang X, et al. Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases. Pharmacol Ther, 2021,217:107659","journal-title":"Pharmacol Ther"},{"issue":"07","key":"2725_CR9","first-page":"496","volume":"47","author":"X Kong","year":"2020","unstructured":"Kong X, Zuo H, Li Y. Pharmacological effects and clinical application of tetrandrine: research advances. J Int Pharm Res, 2020,47(07):496\u2013501","journal-title":"J Int Pharm Res"},{"issue":"11","key":"2725_CR10","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/jphp.13339","volume":"72","author":"F Luan","year":"2020","unstructured":"Luan F, He X, Zeng N. Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems. J Pharm Pharmacol, 2020,72(11):1491\u20131512","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"2725_CR11","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1021\/acs.molpharmaceut.0c00026","volume":"17","author":"W Su","year":"2020","unstructured":"Su W, Liang Y, Meng Z, et al. Inhalation of Tetrandrine-hydroxypropyl-\u03b2-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment. Mol Pharm, 2020,17(5):1596\u20131607","journal-title":"Mol Pharm"},{"key":"2725_CR12","doi-asserted-by":"publisher","first-page":"1926947","DOI":"10.1155\/2020\/1926947","volume":"2020","author":"Z Liu","year":"2020","unstructured":"Liu Z, Li Y, Guo F, et al. Tetrandrine Inhibits Titanium Particle-Induced Inflammatory Osteolysis through the Nuclear Factor-\u03baB Pathway. Mediators Inflamm, 2020,2020:1926947","journal-title":"Mediators Inflamm"},{"issue":"3","key":"2725_CR13","first-page":"2670","volume":"16","author":"X Li","year":"2018","unstructured":"Li X, Wu Z, He B, et al. Tetrandrine alleviates symptoms of rheumatoid arthritis in rats by regulating the expression of cyclooxygenase-2 and inflammatory factors. Exp Ther Med, 2018,16(3):2670\u20132676","journal-title":"Exp Ther Med"},{"key":"2725_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","volume":"44","author":"T Wang","year":"2018","unstructured":"Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev, 2018,44:38\u201350","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"2725_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, Lepus CM, Wang Q, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol, 2016,12(10):580\u2013592","journal-title":"Nat Rev Rheumatol"},{"issue":"18","key":"2725_CR16","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.2174\/1381612824666180629111227","volume":"24","author":"K Takeuchi","year":"2018","unstructured":"Takeuchi K, Amagase K. Roles of Cyclooxygenase, Prostaglandin E2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract. Curr Pharm Des, 2018,24(18):2002\u20132011","journal-title":"Curr Pharm Des"},{"issue":"11","key":"2725_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/apt.14610","volume":"47","author":"ND Yeomans","year":"2018","unstructured":"Yeomans ND, Graham DY, Husni ME, et al. Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Aliment Pharmacol Ther, 2018,47(11):1453\u20131463","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2725_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/gut.47.6.762","volume":"47","author":"LM Jackson","year":"2000","unstructured":"Jackson LM, Wu KC, Mahida YR, et al. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut, 2000,47(6):762\u2013770","journal-title":"Gut"},{"issue":"2","key":"2725_CR19","doi-asserted-by":"publisher","first-page":"e0009115","DOI":"10.1371\/journal.pntd.0009115","volume":"15","author":"PV Aguilar","year":"2021","unstructured":"Aguilar PV, Bedoui Y, Septembre-Malaterre A, et al. Robust COX-2-mediated prostaglandin response may drive arthralgia and bone destruction in patients with chronic inflammation post-chikungunya. PLoS Negl Trop Dis, 2021,15(2):e0009115","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"2725_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4166\/kjg.2016.67.6.300","volume":"67","author":"YK Shim","year":"2016","unstructured":"Shim YK, Kim N. Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease. Korean J Gastroenterol, 2016,67(6):300\u2013312","journal-title":"Korean J Gastroenterol"},{"issue":"9","key":"2725_CR21","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1136\/annrheumdis-2013-203416","volume":"73","author":"S Ashraf","year":"2014","unstructured":"Ashraf S, Mapp PI, Burston J, et al. Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis. Ann Rheum Dis, 2014,73(9):1710\u20131718","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2725_CR22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.joca.2018.05.021","volume":"26","author":"K Nakata","year":"2018","unstructured":"Nakata K, Hanai T, Take Y, et al. Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review. Osteoarthritis Cartilage, 2018,26(10):1263\u20131273","journal-title":"Osteoarthritis Cartilage"},{"key":"2725_CR23","first-page":"e50924","volume":"84","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Liu B, Liu CJ. Establishment of a surgically-induced model in mice to investigate the protective role of progranulin in osteoarthritis. J Vis Exp, 2014,84:e50924","journal-title":"J Vis Exp"},{"key":"2725_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bcp.2015.11.025","volume":"101","author":"X Yuan","year":"2016","unstructured":"Yuan X, Tong B, Dou Y, et al. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor. Biochem Pharmacol, 2016,101:87\u201399","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2725_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-019-1411-x","volume":"16","author":"HC Xiang","year":"2019","unstructured":"Xiang HC, Lin LX, Hu XF, et al. AMPK activation attenuates inflammatory pain through inhibiting NF-\u03baB activation and IL-1\u03b2 expression. J Neuroinflammation. 2019,16(1):34","journal-title":"J Neuroinflammation"},{"issue":"9","key":"2725_CR26","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s10072-019-03884-6","volume":"40","author":"J Khan","year":"2019","unstructured":"Khan J, Ali G, Khan R, et al. Attenuation of vincristine-induced neuropathy by synthetic cyclohexenone-functionalized derivative in mice model. Neurol Sci, 2019,40(9):1799\u20131811","journal-title":"Neurol Sci"},{"issue":"5","key":"2725_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/md17050265","volume":"17","author":"H Wang","year":"2019","unstructured":"Wang H, Li X, Zhangsun D, et al. The \u03b19\u03b110 Nicotinic Acetylcholine Receptor Antagonist \u03b1O-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain. Mar Drugs, 2019,17(5):265","journal-title":"Mar Drugs"},{"issue":"Suppl3","key":"2725_CR28","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","volume":"18","author":"SS Glasson","year":"2010","unstructured":"Glasson SS, Chambers MG, Van Den Berg WB, et al. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage, 2010,18 Suppl 3:S17\u201323","journal-title":"Osteoarthritis Cartilage"},{"key":"2725_CR29","doi-asserted-by":"publisher","first-page":"1759720X1986449","DOI":"10.1177\/1759720X19864492","volume":"11","author":"A Ghouri","year":"2019","unstructured":"Ghouri A, Conaghan PG. Update on novel pharmacological therapies for osteoarthritis. Ther Adv Musculoskelet Dis, 2019,11:1759720X19864492","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"2725_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-018-1286-2","volume":"10","author":"Y Jia","year":"2019","unstructured":"Jia Y, Tao Y, Lv C, et al. Tetrandrine enhances the ubiquitination and degradation of Syk through an AhR-c-src-c-Cbl pathway and consequently inhibits osteoclastogenesis and bone destruction in arthritis. Cell Death Dis, 2019,10(2):38","journal-title":"Cell Death Dis"},{"issue":"4","key":"2725_CR31","doi-asserted-by":"publisher","first-page":"e94586","DOI":"10.1371\/journal.pone.0094586","volume":"9","author":"H Zhao","year":"2014","unstructured":"Zhao H, Luo F, Li H, et al. Antinociceptive effect of tetrandrine on LPS-induced hyperalgesia via the inhibition of IKKbeta phosphorylation and the COX-2\/PGE(2) pathway in mice. PLoS One, 2014,9(4):e94586","journal-title":"PLoS One"},{"key":"2725_CR32","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","volume":"2","author":"J Martel-Pelletier","year":"2016","unstructured":"Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. Nat Rev Dis Primers. 2016,2:16072","journal-title":"Nat Rev Dis Primers"},{"key":"2725_CR33","doi-asserted-by":"publisher","first-page":"8293921","DOI":"10.1155\/2020\/8293921","volume":"2020","author":"YY Chow","year":"2020","unstructured":"Chow YY, Chin KY. The Role of Inflammation in the Pathogenesis of Osteoarthritis. Mediators Inflamm, 2020,2020:8293921","journal-title":"Mediators Inflamm"},{"key":"2725_CR34","doi-asserted-by":"publisher","first-page":"147894","DOI":"10.1155\/2015\/147894","volume":"2015","author":"Z Jia","year":"2015","unstructured":"Jia Z, Zhang Y, Ding G, et al. Role of COX-2\/mPGES-1\/prostaglandin E2 cascade in kidney injury. Mediators Inflamm, 2015,2015:147894","journal-title":"Mediators Inflamm"},{"key":"2725_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41413-019-0071-x","volume":"7","author":"M Tu","year":"2019","unstructured":"Tu M, Yang M, Yu N, et al. Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis. Bone Res, 2019,7:29","journal-title":"Bone Res"}],"updated-by":[{"DOI":"10.1007\/s11596-023-2773-y","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000}}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-023-2725-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-023-2725-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-023-2725-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T07:09:10Z","timestamp":1702451350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-023-2725-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2725"],"URL":"https:\/\/doi.org\/10.1007\/s11596-023-2725-6","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s11596-023-2773-y","asserted-by":"object"}]},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"8 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}